Product Overview

Rabeprazole Sodium IP 20 mg [Enteric Coated] + Levosulpiride 75 mg [Sustained Release] is a combination pharmaceutical formulation developed for the management of acid-related gastrointestinal conditions accompanied by impaired gastric motility and digestive discomfort. The formulation combines effective gastric acid suppression with a prokinetic agent to provide comprehensive support for patients experiencing symptoms such as acid reflux, heartburn, indigestion, bloating, nausea, and delayed gastric emptying under medical supervision.

Rabeprazole Sodium belongs to the proton pump inhibitor (PPI) class and works by reducing gastric acid production in the stomach. It inhibits the proton pumps responsible for the final stage of acid secretion, helping control excessive acidity, relieve heartburn and acid reflux, and support the healing of acid-related irritation in the gastrointestinal tract.

Levosulpiride is a gastrointestinal prokinetic agent that helps improve gastric and intestinal motility. It promotes coordinated movement of food through the digestive tract and can help improve symptoms associated with delayed gastric emptying, including bloating, fullness, nausea, and upper abdominal discomfort.

The combination provides a dual-action approach by addressing both excessive gastric acid production and impaired gastrointestinal motility. The enteric-coated form of Rabeprazole is designed to protect the active ingredient from degradation in the acidic stomach environment, while the sustained-release form of Levosulpiride is designed to provide prolonged release and consistent therapeutic support.

Key Features

• Dual-action gastrointestinal formulation
• Helps reduce excessive gastric acid production
• Supports relief from acidity, heartburn, and acid reflux
• Promotes healthy gastrointestinal motility
• Helps manage bloating, fullness, and digestive discomfort
• Enteric-coated and sustained-release formulation
• Reliable and consistent therapeutic performance

Uses

• Gastroesophageal reflux disease (GERD) management
• Acidity and heartburn relief
• Acid reflux symptom management
• Functional dyspepsia support
• Delayed gastric emptying and impaired motility management
• Bloating, nausea, and upper abdominal discomfort associated with gastrointestinal disorders

How It Works

Rabeprazole Sodium reduces gastric acid secretion by inhibiting proton pumps in the stomach. Levosulpiride supports gastrointestinal motility and promotes coordinated movement of the digestive tract. Together, they help manage both acid-related symptoms and motility-associated digestive discomfort.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea or constipation
• Bloating
• Dizziness
• Fatigue

Patients should seek medical attention if severe allergic reactions, persistent abdominal pain, unusual movements, or other serious symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver, kidney, neurological, or hormonal conditions
• Inform your healthcare provider about all medications being taken
• Avoid prolonged self-medication
• Pregnant or breastfeeding women should consult a healthcare professional before use

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured under stringent pharmaceutical quality control procedures, the formulation undergoes comprehensive testing to ensure purity, safety, consistency, and dependable therapeutic performance. Each batch is carefully evaluated to maintain consistent pharmaceutical quality and reliable healthcare standards.